These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 33370413)

  • 1. Phylogenomics of 8,839 Clostridioides difficile genomes reveals recombination-driven evolution and diversification of toxin A and B.
    Mansfield MJ; Tremblay BJ; Zeng J; Wei X; Hodgins H; Worley J; Bry L; Dong M; Doxey AC
    PLoS Pathog; 2020 Dec; 16(12):e1009181. PubMed ID: 33370413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtyping analysis reveals new variants and accelerated evolution of Clostridioides difficile toxin B.
    Shen E; Zhu K; Li D; Pan Z; Luo Y; Bian Q; He L; Song X; Zhen Y; Jin D; Tao L
    Commun Biol; 2020 Jul; 3(1):347. PubMed ID: 32620855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative genomics of
    Janezic S; Dingle K; Alvin J; Accetto T; Didelot X; Crook DW; Lacy DB; Rupnik M
    Microb Genom; 2020 Oct; 6(10):. PubMed ID: 33030421
    [No Abstract]   [Full Text] [Related]  

  • 4. Genomic and phenotypic studies among
    Meléndez-Sánchez D; Hernández L; Ares M; Méndez Tenorio A; Flores-Luna L; Torres J; Camorlinga-Ponce M
    Microbiol Spectr; 2024 Jul; 12(7):e0394723. PubMed ID: 38864670
    [No Abstract]   [Full Text] [Related]  

  • 5. The complexity and diversity of the Pathogenicity Locus in Clostridium difficile clade 5.
    Elliott B; Dingle KE; Didelot X; Crook DW; Riley TV
    Genome Biol Evol; 2014 Nov; 6(12):3159-70. PubMed ID: 25381663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of pathogenicity locus (PaLoc) and tcdC genetic diversity among tcdA
    Kodori M; Ghalavand Z; Yadegar A; Eslami G; Azimirad M; Krutova M; Abadi A; Zali MR
    Anaerobe; 2020 Dec; 66():102294. PubMed ID: 33181348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis and genotyping of pathogenicity locus in Clostridioides difficile strains isolated from patients in Tehran hospitals during the years 2007-2010.
    Azimirad M; Azizi O; Alebouyeh M; Aslani MM; Mousavi SF; Zali MR
    Infect Genet Evol; 2019 Jul; 71():205-210. PubMed ID: 30902742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the frequency of Clostridium difficile tcdA, tcdB, cdtA and cdtB genes in feces of Calves in south west of Iran.
    Doosti A; Mokhtari-Farsani A
    Ann Clin Microbiol Antimicrob; 2014 Jun; 13():21. PubMed ID: 24903619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence variation in tcdA and tcdB of Clostridium difficile: ST37 with truncated tcdA is a potential epidemic strain in China.
    Du P; Cao B; Wang J; Li W; Jia H; Zhang W; Lu J; Li Z; Yu H; Chen C; Cheng Y
    J Clin Microbiol; 2014 Sep; 52(9):3264-70. PubMed ID: 24958798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease.
    Sambol SP; Merrigan MM; Lyerly D; Gerding DN; Johnson S
    Infect Immun; 2000 Oct; 68(10):5480-7. PubMed ID: 10992443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of BI/NAP1/027 hypervirulent strains reveals novel toxin B-encoding gene (tcdB) sequences.
    Stabler RA; Dawson LF; Phua LTH; Wren BW
    J Med Microbiol; 2008 Jun; 57(Pt 6):771-775. PubMed ID: 18480336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and elimination of a novel non-toxigenic
    Maslanka JR; Gu CH; Zarin I; Denny JE; Broadaway S; Fett B; Mattei LM; Walk ST; Abt MC
    Gut Microbes; 2020 Nov; 12(1):1-15. PubMed ID: 33305657
    [No Abstract]   [Full Text] [Related]  

  • 13. Nanobodies against C. difficile TcdA and TcdB reveal unexpected neutralizing epitopes and provide a toolkit for toxin quantitation in vivo.
    Kordus SL; Kroh HK; Rodríguez RC; Shrem RA; Peritore-Galve FC; Shupe JA; Wadzinski BE; Lacy DB; Spiller BW
    PLoS Pathog; 2023 Oct; 19(10):e1011496. PubMed ID: 37871122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action and epitopes of Clostridium difficile toxin B-neutralizing antibody bezlotoxumab revealed by X-ray crystallography.
    Orth P; Xiao L; Hernandez LD; Reichert P; Sheth PR; Beaumont M; Yang X; Murgolo N; Ermakov G; DiNunzio E; Racine F; Karczewski J; Secore S; Ingram RN; Mayhood T; Strickland C; Therien AG
    J Biol Chem; 2014 Jun; 289(26):18008-21. PubMed ID: 24821719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sequence invariable region in TcdB2 is required for toxin escape from
    Kempher ML; Shadid TM; Larabee JL; Ballard JD
    J Bacteriol; 2024 Jul; 206(7):e0009624. PubMed ID: 38888328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection and characterization of ultrahigh potency designed ankyrin repeat protein inhibitors of C. difficile toxin B.
    Simeon R; Jiang M; Chamoun-Emanuelli AM; Yu H; Zhang Y; Meng R; Peng Z; Jakana J; Zhang J; Feng H; Chen Z
    PLoS Biol; 2019 Jun; 17(6):e3000311. PubMed ID: 31233493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a neutralizing antibody helps identify structural features critical for binding of
    Kroh HK; Chandrasekaran R; Rosenthal K; Woods R; Jin X; Ohi MD; Nyborg AC; Rainey GJ; Warrener P; Spiller BW; Lacy DB
    J Biol Chem; 2017 Sep; 292(35):14401-14412. PubMed ID: 28705932
    [No Abstract]   [Full Text] [Related]  

  • 18. Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.
    Carter GP; Chakravorty A; Pham Nguyen TA; Mileto S; Schreiber F; Li L; Howarth P; Clare S; Cunningham B; Sambol SP; Cheknis A; Figueroa I; Johnson S; Gerding D; Rood JI; Dougan G; Lawley TD; Lyras D
    mBio; 2015 Jun; 6(3):e00551. PubMed ID: 26037121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C-Terminal Domain of Clostridioides difficile TcdC Is Exposed on the Bacterial Cell Surface.
    Oliveira Paiva AM; de Jong L; Friggen AH; Smits WK; Corver J
    J Bacteriol; 2020 Oct; 202(22):. PubMed ID: 32868401
    [No Abstract]   [Full Text] [Related]  

  • 20. The Importance of Therapeutically Targeting the Binary Toxin from
    Abeyawardhane DL; Godoy-Ruiz R; Adipietro KA; Varney KM; Rustandi RR; Pozharski E; Weber DJ
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.